On the Interaction Between Raising and Focus in Sentential Complementation
Studia Linguistica · 1997
DOI: 10.1111/1467-9582.00016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studia Linguistica, 1997. Verfasst von Johan Rooryck. Die Arbeit wurde bisher 12-mal zitiert (Crossref).
Abstract (Originalsprache)
Raising‐to‐subject (SpectAGR S P) verbs such as seem and so‐called ECM or raising‐to‐object (SpecAGR O P) verbs such as believe display a semantic alternation that can be captured in the same way as in Freeze's (1993) and Kayne's (1994) analysis of have and be . With respect to the syntax of the sentential complement of these verbs, it is shown that analyses of raising and ECM in terms of a ‘reduced’ sentential complement are theoretically and empirically untenable. An analysis of raising is developed which requires two steps: in the embedded CP complement of seem/believe , AGR S P first moves to SpecCP before the subject in the embedded SpecAGR S P moves to the matrix SpecAGR S/O P ( seem/believe ) position. The first step is motivated as Focus‐movement, and allows for an explanation of the relation of seem type verbs to verbs of comparison in many languages. The presence of [+Focus] C° in the sentential complement of seem/believe also accounts for Focus‐related restrictions on the subject of the embedded complement of believe type verbs, which were observed by Postal (1974) for a subset of English ECM verbs (his DOC‐verbs) and by Kayne (1981) and Pollock (1985) for French ECM verbs.
Zitieren
APA
Rooryck, J. (1997). On the Interaction Between Raising and Focus in Sentential Complementation. Studia Linguistica. https://doi.org/10.1111/1467-9582.00016
Vancouver
Rooryck J. On the Interaction Between Raising and Focus in Sentential Complementation. Studia Linguistica. 1997. doi:10.1111/1467-9582.00016
BibTeX
@article{Rooryck1997,
author = {Rooryck, Johan},
title = {On the Interaction Between Raising and Focus in Sentential Complementation},
journal = {Studia Linguistica},
year = {1997},
doi = {10.1111/1467-9582.00016}
}
EUVIMED